CIK 0001862150 · <br>Emerging growth company
Cingulate Inc.
Sign in to watch- Ticker
- CING
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863825535
- Phone
- (913) 942-2300
- Business address
- 1901 W. 47TH PLACE, KANSAS CITY, KS, 66205
- Former names
- Cingulate Inc.
Securities
- CING Common Stock Nasdaq
- CINGW Warrants Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-17 | Schaffer Shane J. Chief Executive Officer | Grant or award · Stock Option (right to Buy) | +27,638 | 27,638 | ||
| 2025-01-17 | Brams Matthew EVP and Chief Medical Officer | Grant or award · Stock Option (right to Buy) | +2,748 | 2,748 | ||
| 2024-12-31 | Silva Raul R. EVP and CSO | Grant or award · Stock Option (right to Buy) | +1,000 | 1,000 | ||
| 2024-12-31 | Brams Matthew EVP and Chief Medical Officer | Grant or award · Stock Option (right to Buy) | +1,000 | 1,000 | ||
| 2024-09-30 | Silva Raul R. EVP and CSO | Grant or award · Stock Option (right to Buy) | +1,000 | 1,000 | ||
| 2024-09-30 | Brams Matthew EVP and Chief Medical Officer | Grant or award · Stock Option (right to Buy) | +1,000 | 1,000 | ||
| 2024-08-15 | Myers Laurie EVP and COO | Sale | −202 | $4.17 | $841 | 0 |
| 2024-06-28 | Silva Raul R. EVP and CSO | Grant or award · Stock Option (right to Buy) | +1,000 | 1,000 | ||
| 2024-06-28 | Brams Matthew EVP and Chief Medical Officer | Grant or award · Stock Option (right to Buy) | +1,000 | 1,000 | ||
| 2024-06-12 | Werth Peter J. Director | Grant or award · Stock Option (right to Buy) | +10,000 | 10,000 | ||
| 2024-06-12 | ROBERTS JOHN A Director | Grant or award · Stock Option (right to Buy) | +10,000 | 10,000 | ||
| 2024-06-12 | Lawrence Bryan Jay Director | Grant or award · Stock Option (right to Buy) | +10,000 | 10,000 | ||
| 2024-06-12 | Ervin Jeffrey S Director | Grant or award · Stock Option (right to Buy) | +10,000 | 10,000 | ||
| 2024-06-11 | Werth Peter J. Director | Grant or award · Stock Option (right to Buy) | +6,926 | 6,926 | ||
| 2024-06-11 | Silva Raul R. EVP and CSO | Grant or award · Stock Option (right to Buy) | +63,324 | 63,324 | ||
| 2024-06-11 | Schaffer Shane J. Chief Executive Officer | Grant or award · Stock Option (right to Buy) | +217,677 | 217,677 | ||
| 2024-06-11 | Myers Laurie EVP and COO | Grant or award · Stock Option (right to Buy) | +98,944 | 98,944 | ||
| 2024-06-11 | ROBERTS JOHN A Director | Grant or award · Stock Option (right to Buy) | +5,000 | 5,000 | ||
| 2024-06-11 | ROBERTS JOHN A Director | Grant or award · Stock Option (right to Buy) | +14,750 | 14,750 | ||
| 2024-06-11 | Callahan Jennifer L. SVP and CFO | Grant or award · Stock Option (right to Buy) | +94,986 | 94,986 |
Page 4 of 11 · 202 trades